VP, Alliances & Business Development
Kevin serves as liaison to GMI’s industry partners to ensure the vision for each alliance programme is realised.
He is an experienced and successful strategic leader of clinical business development with a demonstrated history of working in biotechnology, pharmaceuticals, diagnostics and multiple areas of clinical development with research and CE/IVD approved products. He has a strong business development experience coupled with an educational background in biochemistry followed by cancer, stem cells and personalised medicine at the University of Oxford. Kevin honed his technical skills via a lab-based start to his career working at world leading research and pharmaceutical institutes such as Roche, British Biotechnology, The Wellcome Trust Centre for Human Genetics – Oxford University and the GSF Munich.
Kevin has been an instrumental employee in multiple successful startups such as, Affymetrix, NimbleGen, Rules Based Medicine and Complete Genomics. He has been invited to Number 10 Downing Street as an industry expert for the 100,000 Genomes project and is currently an external diagnostics advisor to the Academic Health Scientific Network.